So, ImmunityBio (IBRX 3.80%). It went up. Again. 17.39% today. You know, it’s just… it’s irritating. Like, they had an FDA meeting. An “End-of-Phase” meeting. What even is an End-of-Phase meeting? Sounds like a support group for people who’ve completed clinical trials. And now, because of this meeting, the stock jumps? It closed at $6.48. Six dollars and forty-eight cents. It’s just… a number.
And the volume? 209.3 million shares. A thousand percent above the average. People are trading this thing like it’s going to cure… something. It’s bladder cancer, apparently. Look, I’m not minimizing bladder cancer, okay? But the market’s reaction is… disproportionate. The stock’s been down 81% since the IPO in 2015, so, naturally, now it’s a hot commodity? It’s like they’re rewarding failure. It’s just… wrong.
How the markets moved today
The S&P 500, predictably, went down. 2.06%. Because of course it did. The Nasdaq Composite, same story. 2.39%. It’s like a coordinated effort to make me feel bad about my portfolio. Moderna was up, though. 4.56%. And Novavax? Up a measly 0.49%. Like they’re trying to send a message. “See? Some biotech stocks go up. You’re just unlucky.” It’s infuriating.
What this means for investors
Okay, so ImmunityBio’s stock doubled last week. Doubled. And then it goes up again today? It’s a resubmission path for ANKTIVA, for BCG-unresponsive papillary bladder cancer. Papillary. Papillary! They use words like that to intimidate you. It’s like they’re saying, “You don’t understand science, do you?”
They’re talking about triple-digit sales growth. “Off a small base,” they conveniently add. Of course it’s off a small base! Everything is off a small base! It’s just… deceptive. It’s a tiny little uptick, and they’re acting like it’s a revolution.
They say there’s “upside.” Upside to what? More disappointment? More volatility? It’s going to be a “volatile ride,” they warn. Like I don’t know that already. It’s the stock market. It’s always a volatile ride. And now, because of a meeting, and a potential resubmission, people are throwing money at this thing? It’s just… unbelievable. I need a nap.
Read More
- Building 3D Worlds from Words: Is Reinforcement Learning the Key?
- Securing the Agent Ecosystem: Detecting Malicious Workflow Patterns
- Gold Rate Forecast
- 2025 Crypto Wallets: Secure, Smart, and Surprisingly Simple!
- The Best Directors of 2025
- TV Shows Where Asian Representation Felt Like Stereotype Checklists
- Mel Gibson, 69, and Rosalind Ross, 35, Call It Quits After Nearly a Decade: “It’s Sad To End This Chapter in our Lives”
- Games That Faced Bans in Countries Over Political Themes
- 📢 New Prestige Skin – Hedonist Liberta
- Most Famous Richards in the World
2026-01-27 01:12